omniture
Antennova

Latest News

Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024

* In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to...

2024-09-16 18:00 2089

Antennova to Present Latest Data of ATN-037 in a Mini Oral Presentation at ESMO Congress 2024

BOSTON, Sept. 8, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncolo...

2024-09-09 08:30 1123

Antennova Announces CD73 Small Molecule Inhibitor Accepted for Mini Oral Presentation at ESMO Congress 2024

BOSTON, Aug. 5, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncolog...

2024-08-05 20:00 1616

Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study

* ATN-031 (also known as ATG-031), is the first anti-CD24 antibody to advance to the clinic in on...

2024-03-20 20:30 2504